XML 65 R46.htm IDEA: XBRL DOCUMENT v3.25.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2024
Income Taxes  
Schedule of composition of income tax expenses

For the year ended December 31,

    

2022

    

2023

    

2024

 

RMB’000

 

RMB’000

RMB’000

Current income tax expense/(credit)

361

(42)

64

Deferred taxation

 

Total

 

361

(42)

64

Schedule of reconciliation of the differences between statutory income tax rate and the effective income tax rate

For the year ended December 31,

    

2022

    

2023

    

2024

 

%

 

%

%

Statutory EIT rate

25.00

25.00

25.00

Effect of non-deductible expenses/(gain) (1)

 

16.97

 

(1.87)

(0.18)

Tax incentives for research and development expense (2)

 

(49.14)

 

11.32

2.23

Tax incentives for wages of disabled staff

 

(0.16)

 

0.05

0.02

Preferential tax rate

(4.20)

0.62

0.19

Change in valuation allowance

 

2.52

 

(33.14)

(26.59)

Tax rate difference from statutory rate in other jurisdictions

 

10.44

 

(1.93)

(0.72)

Effective income tax rate

 

1.43

 

0.05

(0.05)

(1)Primarily comprised of share-based compensation expenses/(gain) which are permanent differences.
(2)According to policies promulgated by the State Tax Bureau of the PRC, certain of the Group’s subsidiaries are entitled to tax incentives for research and development expenses at 175% of tax-deductible research and development expenses in 2021 and January 1, 2022 to September 30, 2022. Under Chinese mainland regulations issued in September 2022 that were applicable from October 1, 2022 to December 31, 2024, certain of the Group’s subsidiaries are entitled to tax incentives for research and development expenses at 200% of tax-deductible research and development expenses.
Schedule of composition of deferred tax assets

December 31, 

December 31, 

    

2023

    

2024

RMB’000

RMB’000

Deferred tax assets - non‑current:

—Net operating tax losses carry forwards

 

69,061

 

67,468

—Allowances of doubtful accounts

 

11,656

 

16,108

— Investment loss

1,747

7,263

—Others

2,550

Total deferred tax assets

 

82,464

 

93,389

Less: valuation allowance

 

(79,533)

 

(93,237)

Total deferred tax assets, net

 

2,931

 

152

Deferred tax liabilities - non‑current:

— Unrealized investment gain

(2,931)

(152)

Total deferred tax liabilities

(2,931)

(152)